Floatz logo

Therapeutic Asset Ratings

622 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications
Methodology v0.2
AssetSponsorPhaseRating
p2et
Breast Cancer
Hospital Universitario San IgnacioP2CC (46)
Parstuzumab
Breast Cancer
Henan Cancer HospitalP2CC (46)
PCS6422
Breast Cancer
Processa PharmaceuticalsP2CC (46)
Penpulimab
Breast Cancer
West China HospitalP2CC (46)
PF-0704091
Breast Cancer
PfizerP2CC (46)
Posaconazole
Breast Cancer
Shandong Cancer Hospital and InstituteP2CC (46)
Ptc-Pz
Breast Cancer
Borstkanker Onderzoek GroepP2CC (46)
Pudexacianinium Chloride
Breast Cancer
Astellas Pharma IncP2CC (46)
Pyrrolidone
Breast Cancer
Xijing HospitalP2CC (46)
qbs72s
Breast Cancer
Stanford UniversityP2CC (46)
rc148
Breast Cancer
RemeGen Co., Ltd.P2CC (46)
(R)-CETIRIZINE
Breast Cancer
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityP2CC (46)
Rfsh
Breast Cancer
Institut Cancerologie de l'OuestP2CC (46)
ro7247669
Breast Cancer
Hoffmann-La RocheP2CC (46)
Romiplostim
Breast Cancer
Peking University People's HospitalP2CC (46)
Sarilumab
Breast Cancer
QuantumLeap Healthcare CollaborativeP2CC (46)
Serplulimab
Breast Cancer
Xijing HospitalP2CC (46)
Shr-1167
Breast Cancer
Fudan UniversityP2CC (46)
Shr-4602
Breast Cancer
Fudan UniversityP2CC (46)
Shr-6209
Breast Cancer
Fudan UniversityP2CC (46)
Shr-A1811:Pyrotinib
Breast Cancer
Jiangsu HengRui Medicine Co., Ltd.P2CC (46)
Si-B003
Breast Cancer
Sichuan Baili Pharmaceutical Co., Ltd.P2CC (46)
Sleeping Beauty Transposed Pbl
Breast Cancer
National Cancer Institute (NCI)P2CC (46)
Surufatinib
Breast Cancer
The First Affiliated Hospital of Zhengzhou UniversityP2CC (46)
Tagolimumab
Breast Cancer
Sun Yat-sen UniversityP2CC (46)
Showing 326 to 350 of 622 assets
PreviousPage 14 of 25Next